Skip to main content

Table 2 Patient sample characteristics (n = 314) for 3 MOA groups at Pretest (T2)

From: Effects of mode of administration (MOA) on the measurement properties of the EORTC QLQ-C30: a randomized study

QLQ-C30
at pre-test (T2)
Paper & pencil at home
(n = 132)
Telephone
(n = 121)
Paper & pencil in-clinic
(n = 61)
 
  Mean (s.d.) %
floor/ceiling
Mean (s.d.) %
floor/ceiling
Mean (s.d.) %
floor/ceiling
Sig.
Physical function 62.0(28.9) 2%/23% 69.9(23.0) 2%/26% 66.8(24.2) 2%/23% .052
Role function 59.2(31.3) 4%/27% 67.9(28.3) 5%/36% 66.9(28.6) 12%/35% .050
Cognitive function* 80.0(18.4) 0%/43% 82.5(18.9) 1%/50% 87.2(14.4) 0%/39% .038
Emotional function 74.4(21.0) 1%/20% 77.7(19.6) 1%/36% 78.6(18.7) 0%/26% .294
Social function 76.5(27.6) 2%/52% 82.8(20.5) 1%/60% 81.7(22.7) 2%/51% .103
GlobalHealth/QoL 61.5(22.0) 1%/6% 67.2(19.5) 1%/12% 66.1(19.6) 0%/8% .078
Fatigue 45.6(26.0) 13%/3% 38.2(23.5) 21%/3% 40.1(26.9) 15%/3% .060
Nausea/vomitig 14.1(21.3) 69%/1% 10.4(19.0) 76%/1% 13.4(18.5) 62%/2% .321
Pain** 30.5(29.9) 30%/3% 24.7(26.2) 45%/4% 14.8(20.4) 46%/0% .001
Dyspnea 20.1(27.9) 55%/4% 18.1(24.0) 55%/0% 18.0(24.0) 51%/2% .785
Insomnia 30.0(33.8) 52%/8% 29.4(31.8) 63%/2% 21.9(28.5) 57%/3% .226
Anorexia 24.2(29.8) 72%/2% 19.1(29.3) 72%/5% 22.2(29.9) 66%/2% .392
Constipation 11.8(23.8) 83%/2% 7.8(19.2) 87%/1% 12.0(21.1) 82%/0% .268
Diarrhea 10.8(21.7) 85%/1% 11.7(22.7) 85%/0% 4.4(13.0) 87%/0% .074
Financial 8.2(19.0) 82%/1% 5.6(13.9) 89%/2% 3.3(11.7) 90%/0% .117
  1. * p < 0.05 ** p < 0.01